It's just a scoping study, I don't think the market has put any value on Nymagee anyway so if the study comes back as a dud it will have no effect on share price but it won't be vice versa and may even attract a JV partner to that project
The fact that the company has the head space to consider the scoping study is further evidence that the problems of past are behind them.
I can't see any reason why this stock won't stabilise at 35c in the short term
It's just a scoping study, I don't think the market has put any...
Add AMI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
0.010(7.14%) |
Mkt cap ! $253.7M | |||
| Open | High | Low | Value | Volume |
| 14.0¢ | 15.5¢ | 13.8¢ | $1.812M | 12.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 928942 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 329522 | 7 |
View Market Depth
| Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
| AMI (ASX) Chart |